GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bioptik Technology 4161.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

20.65

-0.72%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 837.2m

FY2016FY2025

Net income

TWD 71.2m

FY2016FY2025

Free cash flow

TWD 37.2m

FY2016FY2025

Shareholders' equity

TWD 969.4m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 837.2mTWD 865.3mTWD 828.5mTWD 767.8mTWD 737.9mTWD 485.6mTWD 566.4mTWD 519.5mTWD 476.4mTWD 477.3m
Gross profitTWD 243.5mTWD 267.9mTWD 239.5mTWD 177.5mTWD 163.5mTWD 83.2mTWD 148.6mTWD 126.3mTWD 114.9mTWD 140.6m
Research and developmentTWD 75.2mTWD 75.4mTWD 71.5mTWD 58.3mTWD 48.9mTWD 50.1mTWD 68.6mTWD 57.5mTWD 50.0mTWD 62.5m
Operating income—TWD 90.0mTWD 117.8mTWD 71.8mTWD 27.1m−TWD 59.1mTWD 467,000TWD 726,000TWD 5.0mTWD 17.7m
Net incomeTWD 71.2mTWD 93.6mTWD 85.7mTWD 48.5mTWD 22.6m−TWD 60.0mTWD 5.3mTWD 26.4m−TWD 33.7mTWD 7.7m
Diluted earnings per share1.381.821.671.000.47-1.240.100.51-0.650.14

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 1.57bnTWD 1.49bnTWD 1.50bnTWD 1.52bnTWD 1.52bnTWD 1.47bnTWD 1.55bnTWD 1.60bnTWD 1.57bnTWD 1.52bn
Cash and short-term investments——TWD 394.1mTWD 332.6mTWD 344.8mTWD 409.7m———TWD 626.8m
Total liabilitiesTWD 597.1mTWD 582.5mTWD 673.6mTWD 797.4mTWD 829.4mTWD 738.1mTWD 786.0mTWD 792.1mTWD 678.1mTWD 490.2m
DebtTWD 111.1mTWD 131.9mTWD 523.2mTWD 662.9mTWD 685.9mTWD 640.6mTWD 296.4mTWD 310.7mTWD 325.0mTWD 359.1m
Shareholders' equityTWD 969.4mTWD 901.3mTWD 819.3mTWD 715.1mTWD 690.3mTWD 730.5mTWD 762.8mTWD 804.0mTWD 877.8mTWD 1.03bn
Shares outstanding52m52m51m48m48m48m52m52m52m62m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 60.0mTWD 158.8mTWD 206.0mTWD 55.1m−TWD 41.2mTWD 6.6mTWD 41.0mTWD 41.8mTWD 11.0mTWD 24.5m
Capital spending−TWD 22.8m−TWD 15.5m−TWD 31.0m−TWD 17.1m−TWD 19.8m−TWD 13.2m−TWD 27.4m−TWD 51.0m−TWD 62.7m−TWD 90.0m
Free cash flowTWD 37.2mTWD 143.3mTWD 174.9mTWD 38.0m−TWD 61.0m−TWD 6.6mTWD 13.6m−TWD 9.1m−TWD 51.7m−TWD 65.5m
Dividends paid−TWD 15.9m−TWD 37.1m—−TWD 14.5m−TWD 14.5m−TWD 29.0m−TWD 24.1m−TWD 24.1m−TWD 50.2m−TWD 25.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 237.6mTWD 224.3mTWD 235.8mTWD 215.2mTWD 190.5mTWD 195.7mTWD 227.8mTWD 210.1m
Gross profitTWD 63.7mTWD 65.4mTWD 71.1mTWD 56.8mTWD 51.7mTWD 63.8mTWD 76.1mTWD 64.9m
Operating income—TWD 21.6mTWD 30.8mTWD 9.2mTWD 10.0mTWD 21.9mTWD 36.0mTWD 23.1m
Net incomeTWD 38.6mTWD 17.5mTWD 26.2mTWD 26.2mTWD 4.0mTWD 14.8mTWD 28.6mTWD 18.0m
Diluted earnings per share0.750.340.510.510.080.290.560.35
Cash from operationsTWD 99.0m−TWD 79.0mTWD 53.0mTWD 35.0m−TWD 1.0m−TWD 27.0mTWD 88.0mTWD 56.0m
Capital spending−TWD 4.0m−TWD 2.0m−TWD 4.0m−TWD 10.0m−TWD 3.0m−TWD 4.0m—−TWD 2.0m
Free cash flowTWD 95.0m−TWD 81.0mTWD 49.0mTWD 25.0m−TWD 4.0m−TWD 31.0m—TWD 54.0m
Total assetsTWD 1.62bnTWD 1.58bnTWD 1.57bnTWD 1.46bnTWD 1.42bnTWD 1.47bnTWD 1.49bnTWD 1.50bn
DebtTWD 100.7mTWD 105.9mTWD 111.1mTWD 116.3mTWD 121.5mTWD 126.7mTWD 131.9mTWD 137.2m
Shareholders' equityTWD 988.4mTWD 945.9mTWD 969.4mTWD 941.3mTWD 908.5mTWD 904.5mTWD 901.3mTWD 869.9m

Financial ratios

Data as of 4 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin29.1%31.0%28.9%23.1%22.2%17.1%
Operating margin11.1%13.8%14.2%9.3%3.7%-11.7%
Net margin8.5%10.8%10.3%6.3%3.1%-12.4%
Return on equity7.3%10.4%10.5%6.8%3.3%-8.2%
Return on assets4.5%6.3%5.7%3.2%1.5%-4.1%
Free cash flow yield—16.6%22.6%7.3%-2.2%2.0%
Revenue growth-3.3%4.4%7.9%4.0%52.0%-14.3%
Earnings growth-23.9%9.2%76.7%114.7%-137.7%-1242.4%
Current ratio1.93x1.93x1.69x1.41x1.41x1.56x
Debt to equity0.11x0.15x0.64x0.92x0.99x0.86x
Equity ratio61.7%60.6%54.7%47.2%45.3%49.6%
Interest coverage12.21x13.08x10.71x7.81x3.47x-6.70x
R&D as a share of sales9.0%8.7%8.6%7.6%6.6%10.3%
Buybacks as a share of market value—-0.0%-6.6%0.0%0.0%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue2.9%11.5%6.3%
Net income13.6%—9.9%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin30.0%28.1%26.0%26.6%
Net margin9.7%9.1%5.8%4.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings18.115.017.123.750.2-17.9282.753.1-56.1380.5
Price to sales1.51.61.81.51.52.22.62.74.06.1

Dividends and splits

Per share, in the currency the company pays

Paid for 2 years. Last went ex-dividend on 20 Aug 2025.

FY2025FY2024FY2022
Paid in the year0.300.6190.253
  • 1130-for-1000 split · 20 Aug 2025
  • 1130.0369-for-1000 split · 19 Aug 2025
  • 1050-for-1000 split · 28 Aug 2023
  • 1051.27-for-1000 split · 23 Aug 2018
  • 1147.715-for-1000 split · 9 Sept 2014
  • 1.015-for-1 split · 10 Sept 2012

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.